Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling (Q39924433)

From Wikidata
Jump to navigation Jump to search
scientific article published on 27 October 2008
edit
Language Label Description Also known as
English
Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling
scientific article published on 27 October 2008

    Statements

    Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling (English)
    Ralph T Schermuly
    Peter Ellinghaus
    Hendrik Milting
    Sevdalina Nikolova
    Soni S Pullamsetti
    Norbert Weissmann
    Rajkumar Savai
    Hossein A Ghofrani
    Andreas E Busch
    Stefan Schäfer

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit